-
1
-
2
-
3
Revealing novel protein interaction partners of glyphosate in Escherichia coli
Published 2025-01-01Get full text
Article -
4
Benefits from Long-Term Treatment in Irritable Bowel Syndrome
Published 2012-01-01Get full text
Article -
5
Glutamate Receptors in Neuroinflammatory Demyelinating Disease
Published 2006-01-01“…The search for new MS treatments invariably employs EAE to determine drug activity and provide a rationale for exploring clinical efficacy. The preclinical development of compounds for MS has generally followed a conventional, immunotherapeutic route. …”
Get full text
Article -
6
On QSPR analysis of pulmonary cancer drugs using python-driven topological modeling
Published 2025-02-01“…The integration of computational and mathematical chemistry will make it easier to evaluate drugs because it can assure consistent data for preclinical development. The paper also reveals specific indices that are superior to others regarding predictive accuracy, thus giving a basis for refining the models to suit the individual compound. …”
Get full text
Article -
7
Unwanted disorders and xenogeneic graft‐versus‐host disease in experimental immunodeficient mice: How to evaluate and how to report
Published 2025-01-01“…Abstract Human‐derived tumor models are essential for preclinical development of new anticancer drug entities. Generating animal models bearing tumors of human origin, such as patient‐derived or cell line–derived xenograft tumors, is dependent on immunodeficient strains. …”
Get full text
Article -
8
Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells
Published 2020-01-01“…Laboratory research set the basis for establishing further translation research including preclinical development and proof of concept in model systems. …”
Get full text
Article -
9
A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells
Published 2025-01-01“…Furthermore, SAP UCAR-T cells maintained process stability during scale-up production, indicating the potential for large-scale manufacturing.DiscussionOur findings highlight the SAP module as a promising strategy for the preclinical development of anti-CD70 UCAR-T, paving the way for an 'off-the-shelf' cell therapy product.…”
Get full text
Article -
10
A patient-derived HCC spheroid system to model the tumor microenvironment and treatment response
Published 2025-02-01“…The discovery and preclinical development of compounds targeting HCC are hampered by the absence of authentic tractable systems recapitulating the heterogeneity of HCC tumors in patients and the tumor microenvironment (TME). …”
Get full text
Article